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calicivirus. Actually, RHDV is one of the best
characterized caliciviruses, and the publication
of its full genome sequence in 1991 was the first of
a Caliciviridae member (5).
Diagnostic tools have been developed by our
and other laboratories (3,4,6). Thanks also to
specific monoclonal antibodies produced towards
RHDV and European brown hare syndrome virus
(EBHSV) by our colleague E. Brocchi, we
standardized different enzyme-linked
immunosorbent assays (ELISAs) for the diagno-
sis of related diseases (4,6-8). In particular, we
developed five different ELISAs for serology that
allow the detection of antibodies specific for
RHDV or EBHSV or that are cross-reactive. In
addition, we can define the antibody response in
rabbits and hares in terms of isotype-involved
immunoglobulin M (IgM), IgA, and IgG (9). Today
the main difficulty is the qualitative distinction
between RHDV and rabbit calicivirus (RCV, a
recently identified nonpathogenic calicivirus)
antibodies because of the close antigenic profiles
of these viruses (6). Finally, RHDV- and EBHSV-
specific polymerase chain reaction has been
developed in at least five laboratories besides
ours. We have sent these reagents and/or
diagnostic methods to at least 19 laboratories
outside Italy, including Australia, New Zealand,
and the United States.
Does RHDV infect humans? This question
has arisen together with the prospect of using
RHDV as a biologic control agent in countries like
Australia and New Zealand, when they were free
of RHDV. In Europe, where the disease naturally
occurred and quickly spread, no particular
control on human health was planned. In Italy
only, between 1987 and 1990, hundreds of
millions of rabbits died of RHD in regions where
the average density of humans is very high. As a
consequence of the use of the vaccine since 1991,
the incidence of RHD among breeding rabbits
decreased drastically and quickly. Nevertheless,
the disease is still endemic, mainly in small farms
and among wild rabbits. EBHS also is endemic in
wild hares, and hunters are highly exposed to the
virus since hares are their main target. However,
neither in humans nor in animal species other
than rabbits and hares have any diseases similar
to RHD ever been reported. In relation to the
likelihood of mild or inapparent infections, we
used 100 human sera randomly selected from
blood donors to carry out a preliminary
standardization of an RHD-ELISA that has been
periodically used to control the sera of the RHD
laboratory staff. Very recently, we tested nine
sera from laboratory personnel exposed to
RHDV; again no positive result was noted by
RHD-ELISA. These findings have  limited
epidemiologic value, but considering the high
level of exposure of part of the sample, it is
evident that RHDV infection in humans is
unlikely to be the rule.
Lorenzo Capucci and Antonio Lavazza
Istituto Zooprofilattico Sperimentale della
Lombardia e dell’Emilia, Brescia, Italy
References
  1. Murphy FA. Virus taxonomy. In: Fields BN, Knipe DM,
Howley PM, editors. Virology. 3rd ed. New York:
Lippincott-Raven Publishers; 1996. p. 15-57.
  2. Ohlinger VF, Hass B, Meyers G, Weiland F, Thiel HJ.
Identification and characterization of the virus causing
rabbit hemorrhagic disease. J Virol 1990;64:3331-6.
  3. Rodák L, Šmíd B, Valícek L, Veselý T, Stepánek J,
Hampl J, et al. Enzyme-linked immunosorbent assay
of antibodies to rabbit haemorrhagic disease virus and
determination of its major structural proteins. J Gen
Virol 1990;71:1075-80.
  4. Capucci L, Scicluna MT, Lavazza A. Diagnosis of viral
hemorrhagic disease of rabbits and European brown
hare syndrome. Rev Sci Tech 1991;10:347-70.
  5. Meyers G, Wirblich C, Thiel HJ. Rabbit hemorrhagic
disease virus-molecular cloning and nucleotide
sequencing of a calicivirus genome. Virol 1991;184:664-
76.
  6. Lavazza A, Capucci L. Viral haemorrhagic disease of
rabbits. In: Office International des Epizooties, Paris,
France, Manual of standards for diagnostic test and
vaccine. Paris: the Office; 1996. p. 589-98.
  7. Capucci L, Fusi P, Lavazza A, Pacciarini ML, Rossi C.
Detection and preliminary characterization of a new
rabbit calicivirus related to hemorrhagic disease virus
but nonpathogenic. J Virol 1996;70;8614-23.
  8. Capucci L, Frigoli G, Ronsholt L, Lavazza A, Brocchi E,
Rossi C. Antigenicity of the rabbit hemorrhagic disease
virus studied by its reactivity with monoclonal
antibodies. Virus Res 1995;37:221-38.
  9. Capucci L, Nardin A, Lavazza A. Seroconversion in an
industrial unit of rabbits infected with a non-
pathogenic rabbit haemorrhagic disease-like virus. Vet
Rec 1997;140:647-50.
Rabbit Hemorrhagic Disease
To the Editor: The recent article on calicivirus by
Smith et al. (1) is misleading in its use of the
study concerning human health aspects of rabbit
hemorrhagic disease (RHD) by Mead et al. (2).345 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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The RHD exposure categories of “low” and
“high” used by Mead et al. and mentioned in the
first column of page 18 (1) are not related to the
categories of “low” and “high” given in the same
paragraph at the top of the second column. The
reader might easily assume that it was Mead et
al. who considered that Jul–Dec 1995 was “a low
exposure period.” This is not so—such a
classification is made by Smith et al.
Further, the reader might assume that it was
the study by Mead et al. that concluded “that
exposure to RHD virus remains a plausible
explanation for increased disease incidence.”
Again this is an inference drawn by Smith et al.
and is the opposite of the conclusion of Mead et al.
The basis of exposure in the study by Mead et
al. is at an individual level—the respondents
were chosen either because they had been
handling rabbits or as controls in determining the
level of disease. In contrast, Smith et al. consider
exposure at a broad environmental level and
disregard whether the respondents had been
handling infected rabbits or not. Actually, more
contact with rabbits occurred during the first half
of the study than during the second.
Smith et al. do not mention the conclusions of
Mead et al.: These neither showed any significant
difference between levels or types of illness in
those exposed and those not exposed to RHD
virus nor demonstrated any association between
the exposure to RHD and number of episodes of
illness in the subsequent 1 to 2 months.
The results of the study by Mead et al. may be
summarized by noting that the average number
of episodes of illness over the 13-month reporting
period was 2.6 for respondents who had not been
exposed to RHD virus, 2.2 for those classified as
having a low level of exposure, and 2.3 for those
classified as having a high level.
The study by Mead et al. concluded that, on
the basis of the health survey and the lack of any
serologic reaction of the respondents, there was
considerable support to the view that RHD virus
is not associated with infection or disease in
humans. The results of the study have been
submitted for publication in a scientific journal.
Reference 31 should refer to the Bureau of
Resource Sciences (not Studies).
C. Mead
Convenor, Rabbit Calicivirus Human Health Study
Group, Department of Health and Family Services,
Canberra, Australia
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Reply to Drs. Capucci, Lavazza, and Mead
To the Editor: We are aware of Capucci and
Lavazza’s excellent work. Indeed, one of the best
characterized calicivirus genomes is that de-
tected in rabbit hemorrhagic disease (RHD);
however, the virus’ infectivity, pathogenesis,
modes of transmission, reservoirs, survival in
nature, host of origin, virulence factors, number
of neutralization serotypes, and multispecies
infectivity are poorly characterized. Propagating
this virus in vitro could provide insight for
addressing questions relevant to caliciviruses
that cannot be propagated in vitro.
We are unclear about the confusion regarding
Norwalk virus and feline calicivirus (FCV). Both
are caliciviruses. Norwalk virus is a human
pathogen. FCV is in a different genus (1) that
includes strains infecting humans (2). We know of
no documented FCV infections in humans nor of
detailed studies to search for such occurrences,
although some evidence suggests the possibility
(3).
Capucci and Lavazza’s remaining questions
address the etiology of RHD, diagnostic reagents,
and possible human infection. They report nine
laboratory workers as antibody negative but do
not report test results on persons at high risk,
such as rabbit farm workers, nor do they mention
having positive control human or primate sera.
Koch’s postulates have been fulfilled for RHD: a
parvovirus was isolated in vitro and was cell-
passaged 15 times; at a second laboratory, the
parvovirus was identified in materials causing
RHD (4,5). In Europe the parvovirus etiology for
RHD was deemed hypothetical but has not been
refuted on a scientific basis. The calicivirus
consistently identified in European materials has
not been isolated in vitro, and Koch’s postulates
have not been fulfilled. Are the parvovirus-
associated outbreaks of RHD in Mexico and
China (4,5) and the calicivirus-associated RHD